What are you looking for?

Need help finding what you are looking for? Contact Us

Compare

Free Samples

Home Market Research Reports Pharmaceutical

Vaccines

PUBLISHER: TechNavio | PRODUCT CODE: 1383170

PUBLISHER: TechNavio | PRODUCT CODE: 1383170

Global Human Vaccine Market 2024-2028

PUBLISHED: November 8, 2023

PAGES: 166 Pages

DELIVERY TIME: 1-2 business days

ADD TO COMPARE

SELECT AN OPTION

The human vaccine market is forecasted to grow by USD 29.1 bn during 2023-2028, accelerating at a CAGR of 9.49% during the forecast period. The report on the human vaccine market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increase in pediatric population, need for novel vaccines for chronic infections, and public immunization programs funded by governments.

Market Scope
Base Year	2023
End Year	2028
Series Year	2024-2028
Growth Momentum	Accelerate
YOY 2024	8.56%
CAGR	9.49%
Incremental Value	$29.1bn

Technavio's human vaccine market is segmented as below:

By Route Of Administration

Intramuscular
Subcutaneous
Oral

By End-user

Pediatrics
Adults

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the R and D of novel vaccines as one of the prime reasons driving the human vaccine market growth during the next few years. Also, advancements in vaccine delivery systems and development in nano-particle vaccines will lead to sizable demand in the market.

The report on the human vaccine market covers the following areas:

Human vaccine market sizing
Human vaccine market forecast
Human vaccine market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading human vaccine market vendors that include Astellas Pharma Inc., AstraZeneca Plc, Bavarian Nordic AS, Bharat Biotech Ltd., BioNTech SE, CanSino Biologics Inc., CSL Ltd., Daiichi Sankyo Co. Ltd., Emergent BioSolutions Inc., GlaxoSmithKline Plc, Gradalis Inc., Inovio Pharmaceuticals Inc., Johnson and Johnson, Merck and Co. Inc., Mitsubishi Chemical Group Corp., Moderna Inc., Novavax Inc., Pfizer Inc., Serum Institute of India Pvt. Ltd., and Sanofi SA. Also, the human vaccine market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR70325

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global human vaccine market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global human vaccine market 2018 - 2022 ($ billion)
4.2 Route of Administration Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - Route of Administration Segment 2018 - 2022 ($ billion)
4.3 End-user Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - End-user Segment 2018 - 2022 ($ billion)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)

5 Five Forces Analysis

5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Route of Administration

6.1 Market segments
Exhibit 30: Chart on Route of Administration - Market share 2023-2028 (%)
Exhibit 31: Data Table on Route of Administration - Market share 2023-2028 (%)
6.2 Comparison by Route of Administration
Exhibit 32: Chart on Comparison by Route of Administration
Exhibit 33: Data Table on Comparison by Route of Administration
6.3 Intramuscular - Market size and forecast 2023-2028
Exhibit 34: Chart on Intramuscular - Market size and forecast 2023-2028 ($ billion)
Exhibit 35: Data Table on Intramuscular - Market size and forecast 2023-2028 ($ billion)
Exhibit 36: Chart on Intramuscular - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Intramuscular - Year-over-year growth 2023-2028 (%)
6.4 Subcutaneous - Market size and forecast 2023-2028
Exhibit 38: Chart on Subcutaneous - Market size and forecast 2023-2028 ($ billion)
Exhibit 39: Data Table on Subcutaneous - Market size and forecast 2023-2028 ($ billion)
Exhibit 40: Chart on Subcutaneous - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Subcutaneous - Year-over-year growth 2023-2028 (%)
6.5 Oral - Market size and forecast 2023-2028
Exhibit 42: Chart on Oral - Market size and forecast 2023-2028 ($ billion)
Exhibit 43: Data Table on Oral - Market size and forecast 2023-2028 ($ billion)
Exhibit 44: Chart on Oral - Year-over-year growth 2023-2028 (%)
Exhibit 45: Data Table on Oral - Year-over-year growth 2023-2028 (%)
6.6 Market opportunity by Route of Administration
Exhibit 46: Market opportunity by Route of Administration ($ billion)
Exhibit 47: Data Table on Market opportunity by Route of Administration ($ billion)

7 Market Segmentation by End-user

7.1 Market segments
Exhibit 48: Chart on End-user - Market share 2023-2028 (%)
Exhibit 49: Data Table on End-user - Market share 2023-2028 (%)
7.2 Comparison by End-user
Exhibit 50: Chart on Comparison by End-user
Exhibit 51: Data Table on Comparison by End-user
7.3 Pediatrics - Market size and forecast 2023-2028
Exhibit 52: Chart on Pediatrics - Market size and forecast 2023-2028 ($ billion)
Exhibit 53: Data Table on Pediatrics - Market size and forecast 2023-2028 ($ billion)
Exhibit 54: Chart on Pediatrics - Year-over-year growth 2023-2028 (%)
Exhibit 55: Data Table on Pediatrics - Year-over-year growth 2023-2028 (%)
7.4 Adults - Market size and forecast 2023-2028
Exhibit 56: Chart on Adults - Market size and forecast 2023-2028 ($ billion)
Exhibit 57: Data Table on Adults - Market size and forecast 2023-2028 ($ billion)
Exhibit 58: Chart on Adults - Year-over-year growth 2023-2028 (%)
Exhibit 59: Data Table on Adults - Year-over-year growth 2023-2028 (%)
7.5 Market opportunity by End-user
Exhibit 60: Market opportunity by End-user ($ billion)
Exhibit 61: Data Table on Market opportunity by End-user ($ billion)

8 Customer Landscape

8.1 Customer landscape overview
Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
Exhibit 63: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Exhibit 65: Chart on Geographic comparison
Exhibit 66: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Germany - Market size and forecast 2023-2028
Exhibit 87: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 88: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 89: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.9 China - Market size and forecast 2023-2028
Exhibit 91: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibit 92: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibit 93: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on China - Year-over-year growth 2023-2028 (%)
9.10 UK - Market size and forecast 2023-2028
Exhibit 95: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibit 96: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibit 97: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on UK - Year-over-year growth 2023-2028 (%)
9.11 Canada - Market size and forecast 2023-2028
Exhibit 99: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibit 100: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibit 101: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibit 102: Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 103: Market opportunity By Geographical Landscape ($ billion)
Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ billion)

10 Drivers, Challenges, and Trends

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 105: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends

11 Vendor Landscape

11.1 Overview
11.2 Vendor landscape
Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 107: Overview on factors of disruption
11.4 Industry risks
Exhibit 108: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
Exhibit 109: Vendors covered
12.2 Market positioning of vendors
Exhibit 110: Matrix on vendor position and classification
12.3 Astellas Pharma Inc.
Exhibit 111: Astellas Pharma Inc. - Overview
Exhibit 112: Astellas Pharma Inc. - Product / Service
Exhibit 113: Astellas Pharma Inc. - Key news
Exhibit 114: Astellas Pharma Inc. - Key offerings
12.4 AstraZeneca Plc
Exhibit 115: AstraZeneca Plc - Overview
Exhibit 116: AstraZeneca Plc - Product / Service
Exhibit 117: AstraZeneca Plc - Key news
Exhibit 118: AstraZeneca Plc - Key offerings
12.5 Bavarian Nordic AS
Exhibit 119: Bavarian Nordic AS - Overview
Exhibit 120: Bavarian Nordic AS - Product / Service
Exhibit 121: Bavarian Nordic AS - Key offerings
12.6 Bharat Biotech Ltd.
Exhibit 122: Bharat Biotech Ltd. - Overview
Exhibit 123: Bharat Biotech Ltd. - Product / Service
Exhibit 124: Bharat Biotech Ltd. - Key news
Exhibit 125: Bharat Biotech Ltd. - Key offerings
12.7 CSL Ltd.
Exhibit 126: CSL Ltd. - Overview
Exhibit 127: CSL Ltd. - Business segments
Exhibit 128: CSL Ltd. - Key offerings
Exhibit 129: CSL Ltd. - Segment focus
12.8 Daiichi Sankyo Co. Ltd.
Exhibit 130: Daiichi Sankyo Co. Ltd. - Overview
Exhibit 131: Daiichi Sankyo Co. Ltd. - Product / Service
Exhibit 132: Daiichi Sankyo Co. Ltd. - Key news
Exhibit 133: Daiichi Sankyo Co. Ltd. - Key offerings
12.9 Emergent BioSolutions Inc.
Exhibit 134: Emergent BioSolutions Inc. - Overview
Exhibit 135: Emergent BioSolutions Inc. - Product / Service
Exhibit 136: Emergent BioSolutions Inc. - Key news
Exhibit 137: Emergent BioSolutions Inc. - Key offerings
12.10 GlaxoSmithKline Plc
Exhibit 138: GlaxoSmithKline Plc - Overview
Exhibit 139: GlaxoSmithKline Plc - Business segments
Exhibit 140: GlaxoSmithKline Plc - Key news
Exhibit 141: GlaxoSmithKline Plc - Key offerings
Exhibit 142: GlaxoSmithKline Plc - Segment focus
12.11 Inovio Pharmaceuticals Inc.
Exhibit 143: Inovio Pharmaceuticals Inc. - Overview
Exhibit 144: Inovio Pharmaceuticals Inc. - Product / Service
Exhibit 145: Inovio Pharmaceuticals Inc. - Key news
Exhibit 146: Inovio Pharmaceuticals Inc. - Key offerings
12.12 Merck and Co. Inc.
Exhibit 147: Merck and Co. Inc. - Overview
Exhibit 148: Merck and Co. Inc. - Business segments
Exhibit 149: Merck and Co. Inc. - Key news
Exhibit 150: Merck and Co. Inc. - Key offerings
Exhibit 151: Merck and Co. Inc. - Segment focus
12.13 Mitsubishi Chemical Group Corp.
Exhibit 152: Mitsubishi Chemical Group Corp. - Overview
Exhibit 153: Mitsubishi Chemical Group Corp. - Business segments
Exhibit 154: Mitsubishi Chemical Group Corp. - Key offerings
Exhibit 155: Mitsubishi Chemical Group Corp. - Segment focus
12.14 Moderna Inc.
Exhibit 156: Moderna Inc. - Overview
Exhibit 157: Moderna Inc. - Product / Service
Exhibit 158: Moderna Inc. - Key offerings
12.15 Pfizer Inc.
Exhibit 159: Pfizer Inc. - Overview
Exhibit 160: Pfizer Inc. - Product / Service
Exhibit 161: Pfizer Inc. - Key news
Exhibit 162: Pfizer Inc. - Key offerings
12.16 Sanofi SA
Exhibit 163: Sanofi SA - Overview
Exhibit 164: Sanofi SA - Business segments
Exhibit 165: Sanofi SA - Key news
Exhibit 166: Sanofi SA - Key offerings
Exhibit 167: Sanofi SA - Segment focus
12.17 Serum Institute of India Pvt. Ltd.
Exhibit 168: Serum Institute of India Pvt. Ltd. - Overview
Exhibit 169: Serum Institute of India Pvt. Ltd. - Product / Service
Exhibit 170: Serum Institute of India Pvt. Ltd. - Key offerings

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 171: Inclusions checklist
Exhibit 172: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 173: Currency conversion rates for US$
13.4 Research methodology
Exhibit 174: Research methodology
Exhibit 175: Validation techniques employed for market sizing
Exhibit 176: Information sources
13.5 List of abbreviations
Exhibit 177: List of abbreviations

Product Code: IRTNTR70325

Exhibits:

Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibits6: Executive Summary - Chart on Market Segmentation by End-user
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size - Data Table on global human vaccine market 2018 - 2022 ($ billion)
Exhibits19: Historic Market Size - Route of Administration Segment 2018 - 2022 ($ billion)
Exhibits20: Historic Market Size - End-user Segment 2018 - 2022 ($ billion)
Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
Exhibits23: Five forces analysis - Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition - Five forces 2023 and 2028
Exhibits30: Chart on Route of Administration - Market share 2023-2028 (%)
Exhibits31: Data Table on Route of Administration - Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Route of Administration
Exhibits33: Data Table on Comparison by Route of Administration
Exhibits34: Chart on Intramuscular - Market size and forecast 2023-2028 ($ billion)
Exhibits35: Data Table on Intramuscular - Market size and forecast 2023-2028 ($ billion)
Exhibits36: Chart on Intramuscular - Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Intramuscular - Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Subcutaneous - Market size and forecast 2023-2028 ($ billion)
Exhibits39: Data Table on Subcutaneous - Market size and forecast 2023-2028 ($ billion)
Exhibits40: Chart on Subcutaneous - Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Subcutaneous - Year-over-year growth 2023-2028 (%)
Exhibits42: Chart on Oral - Market size and forecast 2023-2028 ($ billion)
Exhibits43: Data Table on Oral - Market size and forecast 2023-2028 ($ billion)
Exhibits44: Chart on Oral - Year-over-year growth 2023-2028 (%)
Exhibits45: Data Table on Oral - Year-over-year growth 2023-2028 (%)
Exhibits46: Market opportunity by Route of Administration ($ billion)
Exhibits47: Data Table on Market opportunity by Route of Administration ($ billion)
Exhibits48: Chart on End-user - Market share 2023-2028 (%)
Exhibits49: Data Table on End-user - Market share 2023-2028 (%)
Exhibits50: Chart on Comparison by End-user
Exhibits51: Data Table on Comparison by End-user
Exhibits52: Chart on Pediatrics - Market size and forecast 2023-2028 ($ billion)
Exhibits53: Data Table on Pediatrics - Market size and forecast 2023-2028 ($ billion)
Exhibits54: Chart on Pediatrics - Year-over-year growth 2023-2028 (%)
Exhibits55: Data Table on Pediatrics - Year-over-year growth 2023-2028 (%)
Exhibits56: Chart on Adults - Market size and forecast 2023-2028 ($ billion)
Exhibits57: Data Table on Adults - Market size and forecast 2023-2028 ($ billion)
Exhibits58: Chart on Adults - Year-over-year growth 2023-2028 (%)
Exhibits59: Data Table on Adults - Year-over-year growth 2023-2028 (%)
Exhibits60: Market opportunity by End-user ($ billion)
Exhibits61: Data Table on Market opportunity by End-user ($ billion)
Exhibits62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits63: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits65: Chart on Geographic comparison
Exhibits66: Data Table on Geographic comparison
Exhibits67: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits68: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits69: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits70: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits71: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits72: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits73: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits75: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits76: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits77: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits83: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibits84: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibits85: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits88: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits89: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibits92: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibits93: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits96: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits97: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits99: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibits100: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibits101: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits102: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits103: Market opportunity By Geographical Landscape ($ billion)
Exhibits104: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits105: Impact of drivers and challenges in 2023 and 2028
Exhibits106: Overview on Criticality of inputs and Factors of differentiation
Exhibits107: Overview on factors of disruption
Exhibits108: Impact of key risks on business
Exhibits109: Vendors covered
Exhibits110: Matrix on vendor position and classification
Exhibits111: Astellas Pharma Inc. - Overview
Exhibits112: Astellas Pharma Inc. - Product / Service
Exhibits113: Astellas Pharma Inc. - Key news
Exhibits114: Astellas Pharma Inc. - Key offerings
Exhibits115: AstraZeneca Plc - Overview
Exhibits116: AstraZeneca Plc - Product / Service
Exhibits117: AstraZeneca Plc - Key news
Exhibits118: AstraZeneca Plc - Key offerings
Exhibits119: Bavarian Nordic AS - Overview
Exhibits120: Bavarian Nordic AS - Product / Service
Exhibits121: Bavarian Nordic AS - Key offerings
Exhibits122: Bharat Biotech Ltd. - Overview
Exhibits123: Bharat Biotech Ltd. - Product / Service
Exhibits124: Bharat Biotech Ltd. - Key news
Exhibits125: Bharat Biotech Ltd. - Key offerings
Exhibits126: CSL Ltd. - Overview
Exhibits127: CSL Ltd. - Business segments
Exhibits128: CSL Ltd. - Key offerings
Exhibits129: CSL Ltd. - Segment focus
Exhibits130: Daiichi Sankyo Co. Ltd. - Overview
Exhibits131: Daiichi Sankyo Co. Ltd. - Product / Service
Exhibits132: Daiichi Sankyo Co. Ltd. - Key news
Exhibits133: Daiichi Sankyo Co. Ltd. - Key offerings
Exhibits134: Emergent BioSolutions Inc. - Overview
Exhibits135: Emergent BioSolutions Inc. - Product / Service
Exhibits136: Emergent BioSolutions Inc. - Key news
Exhibits137: Emergent BioSolutions Inc. - Key offerings
Exhibits138: GlaxoSmithKline Plc - Overview
Exhibits139: GlaxoSmithKline Plc - Business segments
Exhibits140: GlaxoSmithKline Plc - Key news
Exhibits141: GlaxoSmithKline Plc - Key offerings
Exhibits142: GlaxoSmithKline Plc - Segment focus
Exhibits143: Inovio Pharmaceuticals Inc. - Overview
Exhibits144: Inovio Pharmaceuticals Inc. - Product / Service
Exhibits145: Inovio Pharmaceuticals Inc. - Key news
Exhibits146: Inovio Pharmaceuticals Inc. - Key offerings
Exhibits147: Merck and Co. Inc. - Overview
Exhibits148: Merck and Co. Inc. - Business segments
Exhibits149: Merck and Co. Inc. - Key news
Exhibits150: Merck and Co. Inc. - Key offerings
Exhibits151: Merck and Co. Inc. - Segment focus
Exhibits152: Mitsubishi Chemical Group Corp. - Overview
Exhibits153: Mitsubishi Chemical Group Corp. - Business segments
Exhibits154: Mitsubishi Chemical Group Corp. - Key offerings
Exhibits155: Mitsubishi Chemical Group Corp. - Segment focus
Exhibits156: Moderna Inc. - Overview
Exhibits157: Moderna Inc. - Product / Service
Exhibits158: Moderna Inc. - Key offerings
Exhibits159: Pfizer Inc. - Overview
Exhibits160: Pfizer Inc. - Product / Service
Exhibits161: Pfizer Inc. - Key news
Exhibits162: Pfizer Inc. - Key offerings
Exhibits163: Sanofi SA - Overview
Exhibits164: Sanofi SA - Business segments
Exhibits165: Sanofi SA - Key news
Exhibits166: Sanofi SA - Key offerings
Exhibits167: Sanofi SA - Segment focus
Exhibits168: Serum Institute of India Pvt. Ltd. - Overview
Exhibits169: Serum Institute of India Pvt. Ltd. - Product / Service
Exhibits170: Serum Institute of India Pvt. Ltd. - Key offerings
Exhibits171: Inclusions checklist
Exhibits172: Exclusions checklist
Exhibits173: Currency conversion rates for US$
Exhibits174: Research methodology
Exhibits175: Validation techniques employed for market sizing
Exhibits176: Information sources
Exhibits177: List of abbreviations